WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'7401 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 16'6761 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 120'847  119'361  117'886  116'423  114'968  103'874  86'077  70'353 
Births 2'269  2'287  2'306  2'325  2'344  2'503  2'438  2'375 
Surviving infants 2'236  2'253  2'270  2'288  2'306  2'443  2'350  2'253 
Pop. less than 5 years 11'405  11'501  11'573  11'643  11'697  12'293  11'373  11'237 
Pop. less than 15 years 35'068  35'264  35'419  35'518  35'587  35'399  33'126  31'439 
Female 15-49 years 33'616  33'209  32'796  32'403  31'998  28'614  21'572  15'689 

Number of reported case

(Click for retrospective incidence data for Mexico)
Diphtheria
Japanese encephalitis
Measles 30  68'782  29'730 
Mumps 5'683  2'685  7'475  27'403 
Pertussis 978  252  559  162  53  1'078  5'539 
Polio* 682 
Rubella 46  11'751 
Rubella (CRS)
Tetanus (neonatal) 145 
Tetanus (total) 28  23  39  45  103  381  363 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mexico)
Vaccine year result method % card seen                                                
BCG 1986  73  DHS     99  99  98  99  99  100  67  48 
DTP1 1986  77  DHS     100  96  98  98  99 
DTP3 1986  34  DHS     99  97  95  95  96  97  53  44 
HepB_BD          98  84 
HepB3          99  98  93  95  71  97 
Hib3          99  97  95  95  96  97 
JapEnc         
MCV 1986  59  DHS     99  98  95  96  96  96  75  35 
MCV2          92  97  91  92  94  98 
PCV1          99  97  93  100 
PCV3          99  98  92  46  14 
Pol3 1986  57  DHS     99  97  95  95  96  97  66  91 
Rota1          99  96  97  100 
Rota_last          99  98  90  93  100 
Rubella1          99  98  95  96  95 
TT2plus          90  78 
PAB         
VAD1          94  95  94  100  92 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mexico)
BCG 99  99  98  99  99  99  67  48 
DTP1 99  99  96  98  98  99  77  69 
DTP3 99  97  95  95  96  97  53  44 
HepB3 99  98  93  95  97  97 
Hib3 99  97  95  95  96  97 
MCV 99  98  95  96  96  96  75  35 
PAB 88  88  88  87  87  81  59 
PCV3 99  98  92  46  14 
Pol3 99  97  95  95  96  97  66  91 
Rota_last 99  98  90  93  47 

Number of districts in the country 2'432  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 79
From 80 to 89% 10
From 50 to 79% 9
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA < 8 months;
DTaPHibIPV 2, 4, 6, 18 months;
DTwP 4 years; Yes
HPV 9 years; Yes or 11 years
HepA 1 year;
HepB birth; 2, 6 months; Yes and > 12 years
Influenza 6, 7 months; >50 years Yes and PW
MMR 1, 6 years; Yes
MR 11-12 years; Yes Not having received 2nd dose of MMR
OPV > 6 months; < 5 Years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >=50 years; No
Rotavirus 2, 4 months; Yes
Td 11-12 years (x2); >12 years (x4); Yes and pregnant women
Varicella 1 year;
VitaminA 6-59 months (x2); Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2018  2007-2012    2007-2010  2007-2012  2007-2012  2001-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 236      236  236  236  236 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 2'432  2'456  2'438  2'438  2'438  2'474  2'444 
Nº districts with DTP3 coverage >=80% number 2'162      2'162  2'195  2'461  2'258 
% of districts with DTP3 coverage >=80% From 0 to 100% 89      89  90  99  92 
Nº districts with measles (MCV1) coverage >=95% number 2'031      2'031  2'053     
% of districts with MCV1 coverage >=95% From 0 to 100% 84      83  84     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% NA  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.